173 related articles for article (PubMed ID: 22552000)
1. Giant angiofibromas in tuberous sclerosis complex: a possible role for localized lymphedema in their pathogenesis.
Kacerovska D; Kerl K; Michal M; Filipova H; Vrtel R; Vanecek T; Zelenakova H; Kraus J; Kodet R; Kazakov DV
J Am Acad Dermatol; 2012 Dec; 67(6):1319-26. PubMed ID: 22552000
[TBL] [Abstract][Full Text] [Related]
2. Unilateral facial angiofibromas--a segmental form of tuberous sclerosis.
McGrae JD; Hashimoto K
Br J Dermatol; 1996 Apr; 134(4):727-30. PubMed ID: 8733380
[TBL] [Abstract][Full Text] [Related]
3. Sun exposure causes somatic second-hit mutations and angiofibroma development in tuberous sclerosis complex.
Tyburczy ME; Wang JA; Li S; Thangapazham R; Chekaluk Y; Moss J; Kwiatkowski DJ; Darling TN
Hum Mol Genet; 2014 Apr; 23(8):2023-9. PubMed ID: 24271014
[TBL] [Abstract][Full Text] [Related]
4. The mTOR inhibitor rapamycin significantly improves facial angiofibroma lesions in a patient with tuberous sclerosis.
Hofbauer GF; Marcollo-Pini A; Corsenca A; Kistler AD; French LE; Wüthrich RP; Serra AL
Br J Dermatol; 2008 Aug; 159(2):473-5. PubMed ID: 18547304
[TBL] [Abstract][Full Text] [Related]
5. Analysis of 65 tuberous sclerosis complex (TSC) patients by TSC2 DGGE, TSC1/TSC2 MLPA, and TSC1 long-range PCR sequencing, and report of 28 novel mutations.
Rendtorff ND; Bjerregaard B; Frödin M; Kjaergaard S; Hove H; Skovby F; Brøndum-Nielsen K; Schwartz M;
Hum Mutat; 2005 Oct; 26(4):374-83. PubMed ID: 16114042
[TBL] [Abstract][Full Text] [Related]
6. Unilateral multiple facial angiofibromas: a mosaic form of tuberous sclerosis.
Silvestre JF; Bañuls J; Ramón R; Guijarro J; Botella R; Betlloch I
J Am Acad Dermatol; 2000 Jul; 43(1 Pt 1):127-9. PubMed ID: 10863238
[TBL] [Abstract][Full Text] [Related]
7. New technique using combined pulsed dye laser and fractional resurfacing for treating facial angiofibromas in tuberous sclerosis.
Weiss ET; Geronemus RG
Lasers Surg Med; 2010 Jul; 42(5):357-60. PubMed ID: 20583249
[TBL] [Abstract][Full Text] [Related]
8. A topical combination of rapamycin and tacrolimus for the treatment of angiofibroma due to tuberous sclerosis complex (TSC): a pilot study of nine Japanese patients with TSC of different disease severity.
Wataya-Kaneda M; Tanaka M; Nakamura A; Matsumoto S; Katayama I
Br J Dermatol; 2011 Oct; 165(4):912-6. PubMed ID: 21692771
[TBL] [Abstract][Full Text] [Related]
9. Topical everolimus for facial angiofibromas in the tuberous sclerosis complex. A first case report.
Dill PE; De Bernardis G; Weber P; Lösch U
Pediatr Neurol; 2014 Jul; 51(1):109-13. PubMed ID: 24810875
[TBL] [Abstract][Full Text] [Related]
10. [Multiple and unilateral angiofibromas of the face: forme fruste of Bourneville tuberous sclerosis].
García Muret MP; Pujol RM; de Moragas JM
Ann Dermatol Venereol; 1998 May; 125(5):325-7. PubMed ID: 9747280
[TBL] [Abstract][Full Text] [Related]
11. Segmental tuberous sclerosis presenting as unilateral facial angiofibromas.
Trauner MA; Ruben BS; Lynch PJ
J Am Acad Dermatol; 2003 Aug; 49(2 Suppl Case Reports):S164-6. PubMed ID: 12894111
[TBL] [Abstract][Full Text] [Related]
12. Identification of TSC1 and TSC2 mutations in Korean patients with tuberous sclerosis complex.
Jang MA; Hong SB; Lee JH; Lee MH; Chung MP; Shin HJ; Kim JW; Ki CS
Pediatr Neurol; 2012 Apr; 46(4):222-4. PubMed ID: 22490766
[TBL] [Abstract][Full Text] [Related]
13. A novel topical rapamycin cream for the treatment of facial angiofibromas in tuberous sclerosis complex.
Wheless JW; Almoazen H
J Child Neurol; 2013 Jul; 28(7):933-6. PubMed ID: 23680945
[TBL] [Abstract][Full Text] [Related]
14. Unilateral facial angiofibromas; a review of the literature.
Camprubí M; Balaguer A; Azon Masoliver A; Jiménez-Feijoo R; Escribano Subias J
Pediatr Dermatol; 2006; 23(3):303-5. PubMed ID: 16780491
[No Abstract] [Full Text] [Related]
15. [Tuberous sclerosis in childhood].
Pires CF; Anunciação GM; De Sousa WL; Santos BM; Anunciação FA; Pires AF; Pires LF
Dermatol Online J; 2008 Sep; 14(9):14. PubMed ID: 19061596
[TBL] [Abstract][Full Text] [Related]
16. Tuberous Sclerosis Complex in 29 Children: Clinical and Genetic Analysis and Facial Angiofibroma Responses to Topical Sirolimus.
Wang S; Liu Y; Wei J; Zhang J; Wang Z; Xu Z
Pediatr Dermatol; 2017 Sep; 34(5):572-577. PubMed ID: 28771801
[TBL] [Abstract][Full Text] [Related]
17. Targeted topical and combination laser surgery for the treatment of angiofibromas.
Bae-Harboe YS; Geronemus RG
Lasers Surg Med; 2013 Nov; 45(9):555-7. PubMed ID: 24136238
[TBL] [Abstract][Full Text] [Related]
18. Genital angiofibromas in tuberous sclerosis: two cases.
Nico MM; Ito LM; Valente NY
J Dermatol; 1999 Feb; 26(2):111-4. PubMed ID: 10091481
[TBL] [Abstract][Full Text] [Related]
19. Giant cell angiofibroma of the eyelids: an unusual presentation of tuberous sclerosis.
Mawn LA; Jordan DR; Nerad J; Anderson R; Jabi M
Ophthalmic Surg Lasers; 1999 Apr; 30(4):320-2. PubMed ID: 10219041
[TBL] [Abstract][Full Text] [Related]
20. Analysis of current data on the use of topical rapamycin in the treatment of facial angiofibromas in tuberous sclerosis complex.
Balestri R; Neri I; Patrizi A; Angileri L; Ricci L; Magnano M
J Eur Acad Dermatol Venereol; 2015 Jan; 29(1):14-20. PubMed ID: 25174683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
